Bring Your Product to Germany

Market Access
Strategy

Who should pay for your product: patients, statutory health insurances, or private insurers? Together, we will find your way into the German healthcare market.

498 bn €

Healthcare Spendings
in Germany
(2022)

90%

of the German Population
in Public Health Insurances

74 m

Insurants in
Public Health
Insurances

9 m

Insurants in
Private Health
Insurances

Our Services

“We were looking for expert guidance on our market access strategy and found it in Digital Oxygen. Together with their network, we could exclude inferior options and swiftly focus on the relevant path to reimbursement.”

Dr. Jannik Lockl

CEO and Co-Founder

  • Reimbursement

Via this reimbursement path, your healthcare products will be paid for by statutory health insurances (SHI) – with access to more than 74 million insurants.

The German healthcare system offers a wide range of options to get your healthcare product reimbursed by public health insurers – be it pharmaceutical, medtech, digital or physical. More than 90% of German insurants are insured with a public health insurer, 74 million people in total. As attractive as access to this market is, as complex it is: Aside from strict market access regulation and complex admission processes, economic and medical preconditions, a variety of stakeholders have to be taken into account. From health insurers and governing bodies, to prescribers, their team, and their patients. We assess if an SHI reimbursement path is the best choice for your product, define a clear strategy, and are your partners along the reimbursement path.

  • Out-of-Pocket

Selling your healthcare product as an out-of-pocket offer can be a highly attractive approach – or even the only option if your product is not eligible for reimbursement (yet).

While access to a market of 74 million insurants is certainly attractive, the reimbursement path is not necessarily the best choice for every product – or even an option: For some products, an out-of-pocket strategy might be a much better approach: Be it because of a shorter time-to-market, better pricing options, or simply, because your product does not qualify for the reimbursement path (yet). We assess your market access options, and define your out-of-pocket strategy: From a sound business case to the first-hand validation of your value proposition.

  • Reimbursement (Private Insurers)

Private health insurances can be strong partners for accessing the German healthcare market.

Ca. 10% of German insurants rely on a private health insurer, that’s round about 9 million people. Compared to statutory health insurances, private health insurers frequently offer their customers a broader range of services, including ones that are not (yet) covered by the statutory providers. For you and your product, reimbursement through private health insurances can be an attractive market access option: Private health insurers are not only more open to innovations, but they also make decisions and take action more quickly and are often more flexible in their requirements and processes.

  • Market Access as a Service (MAaS)

Market Access expertise are diverse tasks but also highly time-volatile. We offer you Market Access as a Service – unrestricted know-how, on-demand and when necessary, and thus cost-efficient.

New pproduct prices need to be negotiated with the health insurance funds. The new generation of devices should be included in the reimbursement system as quickly as possible. These are all business-critical tasks – but they arise very irregularly over time. When they do occur, they tend to come in intense phases with tight deadlines. In between, there are often long periods during which little happens apart from occasional relationship management.

With our Market Access as a Service offering, you can comfortably and reliably absorb peak workloads. And when it’s just about keeping contacts warm, you don’t pay for unused capacity.

Our experts have many years of experience in Market Access and know the German healthcare system inside and out – from all angles. This enables us to always provide the exact expertise you need – precisely when you need it.

“We were looking for a thorough assessment of our market access options for the German market. The team at Digital Oxygen delivered: fast, flexibly, reliably, and with exactly the deep market expertise we needed.”

Ben Delhey

CEO

Spotlight
Publications

Advanced Diabetes Technology Landscape 2026

The Advanced Diabetes Technology Landscape 2026 is an extensive overview of companies shaping the future of diabetes care.

Contact

Torsten Christann

Managing Partner

Clients and Partners

 

Abbott

Becton Dickinson

Bitkom

BOYDSense

Coloplast

DDM Health

Deyan7

embecta

enlivio

enovis

eora

Hello Better

inContAlert

Janssen

Jobelius

Korian

Lifescan

Löwenstein Medical

nui

peilivision

Profil Institut

ResMed

SVDGV

SNAQ

Smoke Free

Telecom Design

Tesu health

Tioli

tun

ucura

vitadio

Vitolus

Welt Corp - Digital Health

White Label Advisory

Ypsomed

VibroSense Dynamics

Digital Oxygen

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.